We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Screening, Brief Intervention, and Referral to Treatment for Drug Use (SBIRT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01683227
Recruitment Status : Completed
First Posted : September 11, 2012
Last Update Posted : April 19, 2016
Information provided by (Responsible Party):

September 7, 2012
September 11, 2012
April 19, 2016
April 2010
June 2011   (Final data collection date for primary outcome measure)
past 30 day drug use abstinence [ Time Frame: 6 months post intervention ]
Based on the addiction severity index-Lite
Same as current
Complete list of historical versions of study NCT01683227 on ClinicalTrials.gov Archive Site
Frequency of drug use [ Time Frame: 6 months post intervention ]
Based on composite score from the Addiction Severity Index-Lite
Same as current
Not Provided
Not Provided
Screening, Brief Intervention, and Referral to Treatment for Drug Use
Screening and Brief Intervention for Latino and Non-Latino White Drug Users

Screening, Brief Intervention, and Referral to Treatment (SBIRT) is a comprehensive, integrated public health approach to identify and deliver a spectrum of early detection and intervention services for substance use in general medical care settings. These settings, such as emergency department visits, offer a potential "teachable moment" because patients may have perceptions of vulnerability about their health, and therefore be particularly receptive to screening and counseling. There is mounting scientific evidence suggesting SBIRT is effective in reducing alcohol use at varying levels of severity in a myriad of health care settings including primary care, emergency departments, and trauma centers. Although the SBIRT approach has shown promise for alcohol, relatively little is known about its effectiveness for adult illicit drug use specifically.

This will be among the first studies to rigorously test the SBIRT approach for drug use. It will evaluate the effectiveness of SBIRT for drug use and related factors for 700 multi-ethnic ED patients using a two-group randomized repeated-measures design in which biologically-validated drug use abstinence and related outcomes of an intervention group are compared to those of an attention-placebo control group. Over a 14-month period, bilingual/bicultural Health Educators recruited participants who reported past 30-day illicit drug use in excess of risky alcohol use from the waiting areas of two large hospital's ED and trauma units. Following consent procedures and standardized baseline assessments, Health Educators randomly assigned participants to one of the two conditions. The intervention group received "Life Shift," an SBIRT drug use intervention matched to the participant's drug use risk level. The control group received the same type and quantity of intervention in an unrelated area—Driving and Traffic Safety ("Shift Gears" program), also matched to their driving/traffic risk level. A 6-month face-to-face follow-up visit by trained measurement technicians blind to the participant's assigned condition collected standardized self-report past 30-day drug use measures (ASI-Lite)and hair samples for validating self-reported abstinence. Additional outcome variables are changes in the frequency of drug use, functional status measures (i.e., medical problems, psychiatric problems, and alcohol use), and health care utilization.

Not Provided
Not Provided
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Drug Abuse
  • Behavioral: Screening/motivational drug intervention
    Screening and brief motivational intervention delivered in the ER to reduce drug use
    Other Name: SBIRT
  • Behavioral: Motivational placebo intervention
    Screening and brief motivational intervention delivered in the ER to reduce driving and traffic risk
  • Experimental: Screening/motivational drug intervention
    Screening and brief intervention counseling matched to patient's risk level delivered in the ER
    Intervention: Behavioral: Screening/motivational drug intervention
  • Placebo Comparator: Motivational placebo intervention
    Screening and brief intervention for driving and traffic safety
    Intervention: Behavioral: Motivational placebo intervention

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
August 2012
June 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 18 or over
  • speak English or Spanish
  • competent to give consent and interact
  • drug use risk higher than alcohol use risk

Exclusion Criteria:

  • under 18
  • non english or spanish speaker
  • no telephone where one can be reached
  • too injured/sick to participate
  • alcohol use risk higher than drug use risk
Sexes Eligible for Study: All
18 Years to 100 Years   (Adult, Senior)
Contact information is only displayed when the study is recruiting subjects
United States
1RC1DA028031-01( U.S. NIH Grant/Contract )
Not Provided
Not Provided
Susan I. Woodruff, San Diego State University
San Diego State University
Not Provided
Principal Investigator: Susan I Woodruff, PhD San Diego State University, School of Social Work
San Diego State University
April 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP